U.S. FDA concludes Goa facility inspection, closes with Form-483 and one observation
U.S. FDA inspection at Lupin's Goa facility has concluded.
By ScoutQuest · · 1 min read
- Inspection period
- October 19, 2026 to October 23, 2026
- Outcome
- Form-483 carrying one observation
- Facility
- Goa facility
What the company disclosed
Lupin has informed the National Stock Exchange and BSE that the U.S. FDA has concluded an inspection at its manufacturing facility located in Goa, India.
The inspection in brief
- The inspection was conducted from October 19, 2026 to October 23, 2026.
- It closed with the issuance of a Form-483 with one observation.
What a Form-483 is
A Form-483 is the document the U.S. FDA issues at the close of a facility inspection to record its observations. In this case, the number of observations recorded is one.
What the company says it will do
- Lupin said it will address the observation and respond to the U.S. FDA within the stipulated timeframe.
- The company said it is committed to being compliant with CGMP standards across all its facilities.
How a reader can frame it
- This is an update on the outcome of a regulatory inspection at one manufacturing site, not a financial disclosure. No revenue, profit or product-level figures are part of this update.
- The update records a single observation. The substance of that observation, and the outcome of the company's response, are separate future developments.
- The company's stated position is that it will respond within the timeframe and that it remains committed to CGMP compliance at all its facilities.
The one number that matters here
The update quantifies the outcome as one observation in the Form-483 issued at the close of the inspection.
Also from Lupin
Lupin appoints Brian Savage as President, Chief Legal Officer
23 Oct 2026
Lupin schedules Q2 FY27 earnings call for November 4, 2026 at 18:00 hrs IST
19 Oct 2026
Board meeting on November 03, 2026 to consider and approve September quarter results
19 Oct 2026
More numbers
- Observations in the Form-483 issued at close of inspectionone observation
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.